PTO/AIA/80 (07-12)
`Approvedfor usa through 11/30/2014, OMB 0651-0035
`U.S. Patent and Trademark Office; U.S DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collactton of information unlessit displays a valld OMB control number.
`
`POWEROF ATTORNEY TO PROSECUTEAPPLICATIONS BEFORE THE USPTO
`
`torney givenin the application identified in the attached statement
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`| hereby revoke all previous powers ofat
`under 37 CFR 3.73(c¢).
`| hereby appoint:
`
`00757
`[=] eeassociatedwith CustomerNumber:
`[| Practitioner(s) named below(if more than ten patent practitioners are to be named, then a customer number must be used):
`
`
`Name
`Registration
`Number
`
`
`
`
`
`As attorney(s) or agent(s) to represent the undersigned before the United States Patent and Trademark Office (USPTQ) in connection with
`any and all patent applications assigned only to the undersigned according to the USPTO assignment records or assignments documents
`attached to this form in accordance with 37 CFR 3.73(c).
`
`Please changethe correspondence addressfor the application Identified in the attached statement under 37 CFR 3.73(c) to:
`. [m|
`The address associated with Customer Number:
`00757
`
`OR
`
`
`Y Firm or
`
`Individual Name
`
`
`
`
`
`
`
`
`
`
`Assignee Name and Address: Panasonic Healthcare Co., Ltd.
`
`2131-1 Minamigata, Toon-shi, Ehime, 791-0395, Japan
`
`
`
`A copyof this form, together with a statement under 37 CFR 3,73(c) (Form PTO/AIA/96 or equivalent) is required to be
`
`Flled in each application in which this form is used. The statement under 37 CFR 3.73(c) may be completed by one of
`
`The practitioners appointed In this form, and must identify the application in which this Powerof Attorneyis to befiled.
`
`
`SIGNATUREof Assignee of Record
`The individual whosesignature andtitle Is supplied belowis authorized to act on behalf of the assignee
`
`
`
`
`Date 3/)'
`
`Telephone+81 -89-966-6304
`Daisuke Nggano
`
`Director Intellectual Property Center Authorized Signing Officer for Panasonic Healthcare Co., Ltd.
`This collection of information israquired by 37 CFR 1,31, 1.32 and 1.33. The information is required:to obtain or retain a-benafit by the public which Is to file (and
`by the USPTOto procegs):-an'application, Confidentiality is governed by 35 U.S.C, 122 and 37 CFR 1.11-and 1.14, This collection Is estimated to take 3 minutes
`to complete,including gathering, preparing, and submitting the completed application form to the USPTO.Time wil vary depending upanthe individual case. Any
`comments on the amountof time you require to complete this form and/or suggestionsfor reducing this burden, should be sent to the Chief Information Officer,
`U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMS TO THIS ADDRESS, SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22343-1450,
`
`If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`

`

`Privacy Act Staternent
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the
`requirements of the Act, please be advised that: (1) the general authority for the collection of this information is 35
`U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the
`information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission
`related to a patent application or patent. If you do not furnish the requested information, the U.S. Patent and
`Trademark Office may not be able to process and/or examine your submission, which may result in termination of
`proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`14. The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records
`may be disclosedto the Departmentof Justice to determine whether disclosure of these records is
`required by the Freedom ofInformation Act.
`2. Arecord from this system of records may be disclosed, as a routine use, in the course of presenting
`evidence to a court, magistrate, or administrative tribunal, including disclosures to opposing counselin
`the course of settlement negotiations.
`3. A record in this system of records may bedisclosed, as a routine use, to a Member of Congress
`submitting a request involving anindividual, to whom the record pertains, whenthe individual has
`raquested assistance from the Memberwith respect to the subject matter of the record.
`4. Arecord in this system of records may be disclosed, as a routine use, to a contractor of the Agency
`having needforthe information in order to perform a contract. Recipients of information shall be required
`to comply with the requirementsof the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`5. Arecord related to an International Application filed under the Patent Cooperation Treaty in this system of
`records may be disclosed, as a routine use,to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`6. Arecordin this system of records may be disclosed, as a routine use, to another federal agency for
`purposesof National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act
`(42 U.S.C, 218(c)).
`7. Arecord from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services,or his/her designee, during an inspection of records conducted by GSAaspart of that agency's
`responsibility to recommend improvements in records management practices and programs, under
`authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA
`regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or
`Commerce) directive. Such disclosure shall not be used to make determinations about individuals.
`8. Arecord from this system of records may be disclosed, as a routine use,to the public after either
`publication of the application pursuantto 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C.
`151, Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, asa routine use, to the
`public if the record wasfiled in an application which became abandonedor in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to
`public inspection or an issued patent.
`9. Arecord from this system of records maybe disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency,if the USPTO becomes awareofa violation or potential violation of law or
`regulation.
`
`